You are here: Industry Insights > Laurus Labs

News List

Laurus Labs promoters sell 52 lakh equity shares at aggregate Rs 191.67 crores expresspharma
March 05, 2021
Significant part of the above amount shall be utilised to release the pledge on their equity shares of the company.
Laurus Labs forays into biotech, acquires majority stake in Richcore Lifesciences expresspharma
November 26, 2020
Laurus Labs to acquire 72.55 per cent of Richcore’s shares for a value of Rs 246.7 crores.
Laurus Labs receives USFDA approvals for two ANDAs under PEPFAR expresspharma
May 20, 2020
Laurus Labs is one of the few players in the ARV segment to receive approval for TLE 400 tablets.
Laurus Labs’ PAT touches Rs 110 crore in Q4 expresspharma
May 04, 2020
The consolidated revenue for the quarter was up by 32 per cent to Rs 839 crore as against Rs 635 crore in Q4 FY'19, a press release from the company said.
Laurus Labs and Rising Pharma to collaborate on a clinical trial for preventive COVID-19 treatment expresspharma
April 01, 2020
They will work with University of Minnesota to explore hydroxychloroquine as preventive treatment for coronavirus disease 2019.
Laurus Labs’ distribution partner Rising Pharmaceuticals launches Pregabalin Capsules in US market expresspharma
July 23, 2019
Laurus Labs along with its exclusive distribution partner Rising Pharmaceuticals announced the launch of the generic version of Lyrica, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225
Laurus Labs finishes USFDA inspection of its API facilities in Visakhapatnam expresspharma
June 21, 2019
Laurus Labs announced that it has completed the US Food and Drug Administration (US FDA) inspection of its API facilities in Units 1 & 3 at Parawada, Visakhapatnam, Andhra Pradesh, with two observations which are procedural in nature.
Laurus Labs enters into strategic partnership agreement with Global Fund expressbpd
March 27, 2019
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
Laurus Labs receives two approvals from US FDA expressbpd
March 12, 2019
Receives a final approval for Hydroxychloroquine tablets
Laurus Labs gets EIR from US FDA for AP plants expressbpd
November 15, 2017
Laurus Labs has received Establishment Inspection Report (EIR) from the US Food and Drug Administration(US FDA) for its API (active pharma ingredients) plants located at Visakhapatnam in Andhra Pradesh.

Previous page 1 2 Next page